Synergistic anticancer and antimicrobial efficacy of betanin and IR806 co-encapsulated liposomes against triple-negative breast cancer
Biomedical Materials · 2026
DOI: 10.1088/1748-605x/ae49cd ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Materials, 2026. Verfasst von Chandra Lekha Putta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, Sangareddy 502285, India. Hauptthemen laut MEDLINE: Liposomes, Betacyanins, Triple Negative Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: ARG, MoE, ICMR.
Abstract (Originalsprache)
Breast cancer is the most often diagnosed malignancy in women, exceeding lung cancer with almost 2.3 million new cases per year. Triple-negative breast cancer (TNBC), comprising 10%–15% of cases, is distinguished by its aggressive development, high invasiveness, and restricted treatment alternatives. Patients with malignancies often exhibit impaired immune function, predisposing them to opportunistic infections, particularly those caused by S. aureus (S. aureus) . In this study, the development and characterization of a multifunctional liposomal nanosystem co-delivering betanin and IR806 dye (Bet-IR806-LPs) for the dual management of TNBC and bacterial infections was reported. The liposomes were formulated using soybean phosphatidylcholine (Soya PC), which enhanced drug encapsulation, stability, and biocompatibility. Bet-IR806-LPs exhibited strong photothermal (PTT) conversion efficiency under near-infrared (NIR) irradiation, enabling effective PTT and photodynamic therapy (PDT). Antibacterial assessment against S. aureus revealed potent inhibitory activity, with an IC 50 of 5 μg ml −1 . Biocompatibility was confirmed in fibroblast cell models, while zebrafish assays provided further insights into nanomaterial safety through analyses of reactive oxygen species and apoptosis. Cytotoxicity studies in 4T1 TNBC cells demonstrated significant anti-proliferative and anti-migratory effects, with enhanced tumor cell ablation upon NIR irradiation mediated by combined PTT-PDT mechanisms. Collectively, Bet-IR806-LPs demonstrate promising dual functionality, integrating antibacterial and anticancer activities within a single nanosystem. These findings suggest their potential as a versatile therapeutic platform with clinical relevance for improving treatment outcomes in TNBC while simultaneously addressing bacterial co-infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, Sangareddy 502285, India.
ORCID-Profile: Chandra Lekha Putta, Srujana T L, Aravind Kumar Rengan
Förderung
- ARG
- MoE
- ICMR
- ANRF
- SPARC
Zitieren
APA
Putta, C. L., T L, S., & Rengan, A. K. (2026). Synergistic anticancer and antimicrobial efficacy of betanin and IR806 co-encapsulated liposomes against triple-negative breast cancer. Biomedical Materials. https://doi.org/10.1088/1748-605x/ae49cd
Vancouver
Putta CL, T L S, Rengan AK. Synergistic anticancer and antimicrobial efficacy of betanin and IR806 co-encapsulated liposomes against triple-negative breast cancer. Biomedical Materials. 2026. doi:10.1088/1748-605x/ae49cd
BibTeX
@article{Putta2026,
author = {Putta, Chandra Lekha and T L, Srujana and Rengan, Aravind Kumar},
title = {Synergistic anticancer and antimicrobial efficacy of betanin and IR806 co-encapsulated liposomes against triple-negative breast cancer},
journal = {Biomedical Materials},
year = {2026},
doi = {10.1088/1748-605x/ae49cd}
}
EUVIMED